Net Loss of Sun Pharma Advanced Research Company reported to Rs 80.42 crore in the quarter ended December 2025 as against net loss of Rs 79.51 crore during the previous quarter ended December 2024. Sales declined 43.33% to Rs 8.45 crore in the quarter ended December 2025 as against Rs 14.91 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales8.4514.91 -43 OPM %-670.30-494.23 - PBDT-65.42-76.30 14 PBT-67.99-79.44 14 NP-80.42-79.51 -1 Powered by Capital Market - Live News

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the Company on 9 February 2026.Powered by Capital Market - Live News

Sun Pharma Advanced Research Company announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 9 February 2026.Powered by Capital Market - Live News

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the Company on 14 January 2026.Powered by Capital Market - Live News

Net Loss of Sun Pharma Advanced Research Company reported to Rs 75.85 crore in the quarter ended September 2025 as against net loss of Rs 107.33 crore during the previous quarter ended September 2024. Sales declined 38.88% to Rs 7.86 crore in the quarter ended September 2025 as against Rs 12.86 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales7.8612.86 -39 OPM %-836.13-800.23 - PBDT-73.23-104.01 30 PBT-75.79-107.17 29 NP-75.85-107.33 29 Powered by Capital Market - Live News